Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 477-690-9 | CAS number: 874819-71-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-08-24 - 1004-10-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- OECD 406 (1992)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- At the time of study performance the LLNA was not the current standard test method.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- Species/strain: Guinea-pig/Dunkin Hartley, Crl:(HA)BR
Sex: male
Supplier: Charles River Wiga GmbH, D-97320 Sulzfeld
Age: 16 days - Route:
- other: intracutaneous induction
- Vehicle:
- other: 0.5% solution of Tylose MH 1000 in deionised water
- Concentration / amount:
- Concentration of test material and vehicle used at induction:
Induction: i.c.: 5 % (w/v) suspesion in a 0.5 % (m/v) of Tylose in deionised water
solution of Tylose MH 1000 in
deionised water
Induction: e.c.: 25 % (w/w) mixture of the test item with
vaseline
Concentration of test material and vehicle used for each challenge:
25 % (w/w) mixture of the test item with vaseline - Route:
- epicutaneous, occlusive
- Vehicle:
- other: 0.5% solution of Tylose MH 1000 in deionised water
- Concentration / amount:
- Concentration of test material and vehicle used at induction:
Induction: i.c.: 5 % (w/v) suspesion in a 0.5 % (m/v) of Tylose in deionised water
solution of Tylose MH 1000 in
deionised water
Induction: e.c.: 25 % (w/w) mixture of the test item with
vaseline
Concentration of test material and vehicle used for each challenge:
25 % (w/w) mixture of the test item with vaseline - No. of animals per dose:
- Number of animals in test group: 10
Number of animals in negative control group: 5 - Positive control substance(s):
- not required
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 1.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 25 %. No with. + reactions: 1.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- positive control
- Dose level:
- 25%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- N-(2-Nitrophenyl)phosphoric triamide is not a skin sensitiser.
- Executive summary:
The skin sensitisation potential of the test item N-(2-Nitrophenyl)phosphoric triamide was
investigated in the Guinea-Pig Maximisation Test with the Dunkin Hartley albino strain, whose sensitivity to Benzocaine had been demonstrated, according to OECD guideline 406.
The choice of doses for the main experiment based on the results of the pilot study.
None of the animals died or showed clinical signs during the course of investigation.
The body weights and the body weight gain were not affected by the treatment.
The intracutaneous injection of the 5 % (w/v) suspension of the test item in a 0.5 % Xylose solution induced oedema. In combination with sensitisation potentiating FCA slight to moderate erythema and oedema were observed.
The epicutaneous administration of the 25 % (w/w) mixture of the test item with vaseline did not cause any irritation signs.
The challenge with the 25 % (w/w) mixture of the test item with vaseline caused only a slight erythema in one of the ten animals of the dose group.
The skin fold thickness was not affected by the challenge.
Reference
Maximum concentration not causing irritating effects in preliminary test: 25 %
Signs of irritation during induction:
only after i.c. induction: oedema
Evidence of sensitisation of each challenge concentration:
The administration of the 25 % (w/w) mixture of the test
item with vaseline caused only a slight erythema in one of
the ten animals of the dose group on day 23.
Number of animals with skin sensitisation reaction after administration of N(2-Nitrophenyl)phosphoric triamide (left flank: control; right flank: test item) |
Test group |
Time after challenge |
|||
48hours (Day23) |
72hours (Day24) |
|||
Left flank |
Right flank |
Left flank |
Right flank |
|
Animals with skin sensitisation reaction/used animals |
||||
Control group |
0/5 |
0/5 |
0/5 |
0/5 |
Dose group |
0/10 |
1 / 10 |
0/10 |
1 / 10 |
from this |
|
|
|
|
grade 1 |
|
1/10 |
|
1 / 10 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
A GLP-study was performed to assess the skin sensitisation potential of the test material in the guinea pig. The method used followed that described in the OECD Guidelines for Testing of Chemicals No. 406 (Guinea Pig Maximisation Test).
N-(2-Nitrophenyl)phosphoric triamide was found to be a non-sensitiser to guinea pig skin.
For skin sensitisation, there is no reason to believe that results obtained in experimental animals would not be applicable to humans.
No further testing is required. The available data is adequate for risk assessment and classification and labelling purposes.
Migrated from Short description of key information:
Guinea pig maximisation test: negative
Justification for selection of skin sensitisation endpoint:
Only one study available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
No data gaps were identified. The available data are adequate for risk assessment and classification and labelling purposes.
Justification for classification or non-classification
N-(2-Nitrophenyl)phosphoric triamide is not classified as skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
